Nar H, Werle K, Bauer M M, Dollinger H, Jung B
Department of Medicinal Chemistry, Boehringer Ingelheim Pharma KG, Biberach, Germany.
J Mol Biol. 2001 Sep 28;312(4):743-51. doi: 10.1006/jmbi.2001.4953.
Human macrophage elastase (MMP-12) is a member of the family of matrix metalloproteinases (MMPs) that plays, like other members of the family, an important role in inflammatory processes contributing to tissue remodelling and destruction. In particular, a prominent role of MMP-12 in the destruction of elastin in the lung alveolar wall and the pathogenesis of emphysema has been suggested. It is therefore an attractive therapeutic target. We describe here the crystal structure of the catalytic domain of MMP-12 in complex with a hydroxamic acid inhibitor, CGS27023A. MMP-12 adopts the typical MMP fold and binds a structural zinc ion and three calcium ions in addition to the catalytic zinc ion. The enzyme structure shows an ordered N terminus close to the active site that is identical in conformation with the superactivated form of MMP-8. The S1'-specificity pocket is large and extends into a channel through the protein, which puts MMP-12 into the class of MMPs 3, 8 and 13 with large and open specificity pockets. The two crystallographically independent molecules adopt different conformations of the S1'-loop and its neighbouring loop due to differing crystal packing environments, suggesting that flexibility or the possibility of structural adjustments of these loop segments are intrinsic features of the MMP-12 structure and probably a common feature for all MMPs. The inhibitor binds in a bidentate fashion to the catalytic zinc ion. Its polar groups form hydrogen bonds in a substrate-like manner with beta-strand sIV of the enzyme, while the hydrophobic substituents are either positioned on the protein surface and are solvent-exposed or fill the upper part of the specificity pocket. The present structure enables us to aid the design of potent and selective inhibitors for MMP-12.
人巨噬细胞弹性蛋白酶(MMP - 12)是基质金属蛋白酶(MMPs)家族的成员,与该家族的其他成员一样,在促成组织重塑和破坏的炎症过程中发挥重要作用。特别是,有人提出MMP - 12在肺泡壁弹性蛋白的破坏和肺气肿的发病机制中起显著作用。因此,它是一个有吸引力的治疗靶点。我们在此描述了与异羟肟酸抑制剂CGS27023A复合的MMP - 12催化结构域的晶体结构。MMP - 12采用典型的MMP折叠结构,除了催化锌离子外,还结合一个结构锌离子和三个钙离子。该酶结构显示靠近活性位点的N末端有序,其构象与MMP - 8的超活化形式相同。S1'特异性口袋很大,并延伸到贯穿蛋白质的通道中,这使MMP - 12属于具有大而开放特异性口袋的MMPs 3、8和13类别。由于晶体堆积环境不同,两个晶体学独立分子的S1'环及其相邻环采用不同构象,这表明这些环段的灵活性或结构调整的可能性是MMP - 12结构的固有特征,可能也是所有MMPs的共同特征。抑制剂以双齿方式与催化锌离子结合。其极性基团以类似底物的方式与酶的β链sIV形成氢键,而疏水取代基要么位于蛋白质表面并暴露于溶剂中,要么填充特异性口袋的上部。目前的结构使我们能够辅助设计针对MMP - 12的强效和选择性抑制剂。